Chiglitazar

Overview

Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC 50 s of 1.2, 0.08, 1.7 μM for PPARα , PPARγ and PPARδ , respectively.

Application

Products | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Depression | Products > Disease Areas > Digestive System Inflammation | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Obesity | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PPAR

Product Information

• Catalog No.: HY-106266
• CAS No.: 743438-45-1
• Molecular Formula: C36H29FN2O4
• Molecular Weight: 572.62
• Purity: 99.70%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Solubility: ≥ 2.5 mg/mL (4.37 mM); Clear solution
• Availability: In-stock

Source

Original product source